Advancis Pharmaceutical Corporation
Private placement of common equity closed by pharma firm
Published in Healthcare Mergers, Acquisitions and Ventures Week, June 11th, 2005
The newly issued shares were priced at $3.98, the closing price of the company's common stock on April 25, 2005. As part of the offering, investors also received warrants to purchase approximately 2.4 million shares of common stock, exercisable within 5 years at a price of $4.78 per share.
Following the completion of the offering, Advancis was advised by The Nasdaq Stock Market that the offering was completed at a price determined by Nasdaq...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- A.P. Pharma, Inc.
Pharmaceutical firm reports loss of $0.05 per share, clinical trial update - Abbott
Sales increase 14% for pharmaceutical company - Acadia Pharmaceuticals, Inc.
Biopharmaceutical company reports first quarter loss of $5.6M - Access Pharmaceuticals, Inc.
Pharmaceutical firm records loss of $0.16 per share - Advanced Medical Optics
ReZoom lens to benefit cataract patients under new CMS ruling - Aeolus Pharmaceuticals, Inc.
Pharmaceutical company records loss of $0.12 per share, reports on ALS drug - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
